This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
ZELTIQ Aesthetics, Inc.
ZELTIQ Aesthetics, Inc., commonly known for its innovative CoolSculpting technology, is a leading player in the medical aesthetics industry. Headquartered in the United States, the company has established a significant presence in major operational regions worldwide, focusing on non-invasive body contouring solutions. Founded in 2005, ZELTIQ has achieved notable milestones, including the FDA clearance of its flagship product, CoolSculpting, which revolutionised fat reduction treatments. The core offering, CoolSculpting, utilises advanced cryolipolysis technology to target and eliminate stubborn fat cells without surgery, setting it apart in a competitive market. ZELTIQ's commitment to research and development has solidified its position as a trusted name in aesthetic medicine, with a growing portfolio of products designed to enhance patient outcomes and satisfaction.
DitchCarbon Score
How does ZELTIQ Aesthetics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ZELTIQ Aesthetics, Inc.'s score of 65 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
ZELTIQ Aesthetics, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of AbbVie Inc., which means that any climate commitments or emissions data may be inherited from its parent organisation. ZELTIQ Aesthetics has not outlined any specific reduction targets or initiatives in its own right. However, it is important to note that the climate commitments and reduction strategies may be influenced by AbbVie Inc.'s sustainability efforts. AbbVie has established various climate initiatives, including targets set through the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). As ZELTIQ Aesthetics does not provide its own emissions data or reduction targets, stakeholders may need to refer to AbbVie Inc. for comprehensive insights into the climate commitments and performance metrics relevant to ZELTIQ Aesthetics.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 402,448,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
ZELTIQ Aesthetics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
